Abstract
Summary
Probenecid and bromcresol green (BGr), reported to be PG transport inhibitors, were tested for their effectiveness in modifying the vasopressor responses of arachidonic acid (AA), an endoperoxide analogue, PGF2α, and norepinephrine in the isolated perfused canine lung lobe. Only the pulmonary pressor action of AA was blocked by pretreatment with indomethacin. Probenecid attenuated AA responses and blocked those of PGF2α, in a dose-related manner. BGr had no antagonistic activity against AA and inhibited PGF2α action by 50%. Probenecid and BGr appear to inhibit PGF2α, differently. Neither blocked the pressor action of the endoperoxide analogue, and neither attenuated the norepinephrine pressor action at PG inhibiting concentrations. The use of organic acid transport inhibitors represents a potentially useful approach in studying the mechanisms of action of AA and its metabolic products.
Get full access to this article
View all access options for this article.
